ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 529180 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 529180; 2) Community: the network communities that were significantly associated with the response to NSC 529180; 3) Molecule: the relationships between components within communities and NSC 529180; 4) MDR: the compounds that were significantly associated with the NSC 529180.

NSC Compound Enrichment Correlation
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.0385067071027343 0.0071371328
NSC 757113 METHOTREXATE(+/-) 0.0385067071027343 0.3313998
NSC 761769 Null 0.0385067071027343 -0.0082962849
NSC 107124 Camptothecin Derivative 0.0385067071027345 0.40222774
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0385067071027345 0.27646562
NSC 264880 Dihydro-5-azacytidine 0.0385067071027345 -0.01649278
NSC 268993 Deferoxamine hydrochloride 0.0385067071027345 0.30313155
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0385067071027345 0.44760575
NSC 364830 Camptothecin Derivative 0.0385067071027345 0.39784893
NSC 409304 Null 0.0385067071027345 0.17610745
Total:45  Current:33    [First] [Prev] [Next] [Last]